From: Pathophysiological characterization of asthma transitions across adolescence
Remission | Persistent | Odds ratio | 95% Confidence interval | p-value | |
---|---|---|---|---|---|
Male | n = 17 | n = 40 | |||
FEV1 (L) (S.E.) | 2.6 (0.1) | 2.4 (0.1) | 0.2 | 0.0 to 0.5 | 0.04 |
FVC (L) (S.E.) | 2.3 (0.1) | 2.3 (0.0) | 0.1 | - 0.0 to 0.3 | 0.44 |
FEF25–75% (L/s) (S.E.) | 2.7 (0.2) | 2.1 (0.1) | 0.6 | 0.2 to 1.0 | 0.005 |
Female | n = 7 | n = 45 | |||
FEV1 (L) (S.E.) | 1.4 (0.1) | 1.3 (0.1) | 0.1 | - 0.2 to 0.4 | 0.43 |
FVC (L) (S.E.) | 3.0 (0.1) | 3.1 0.1) | - 0.1 | - 0.4 to 0.2 | 0.67 |
FEF25–75% (L/s) (S.E.) | 1.3 (0.2) | 1.3 (0.1) | 0.1 | - 0.5 to 0.6 | 0.86 |